Non-Invasive Jugular Venous Blood Volume Assessment (BVI)
NCT ID: NCT04208438
Last Updated: 2019-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2019-06-05
2019-10-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BVI Cohort
Cohort to have ultrasound and Mespere BVI device applied.
BVI Device
Non-Invasive measurement of jugular blood volume using Mespere BVI device
Point-of-Care Ultrasound
Point-of-Care ultrasound of external and internal jugular veins
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BVI Device
Non-Invasive measurement of jugular blood volume using Mespere BVI device
Point-of-Care Ultrasound
Point-of-Care ultrasound of external and internal jugular veins
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English-speaking
3. No known medical conditions requiring treatment by a physician
Exclusion Criteria
2. History of congenital heart disease
3. History of thoracic, neck or brain surgery
4. Inability to lay supine at 30 degrees incline or 60 degrees incline for the duration of the study measurements
5. Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mespere Lifesciences Inc.
INDUSTRY
Wayne State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Favot, MD
Associate Professor of Emergency Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integrative Biosciences Center - Clinical Research Service Center
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20201216
Identifier Type: -
Identifier Source: org_study_id